Expediting The Expedited: How Rolling CMC Review Process Is Working For COVID-19 Vaccines
Executive Summary
US, EU and Canadian authorities recently discussed their approaches to rolling reviews of CMC applications for coronavirus vaccines.
You may also be interested in...
The Good, The Bad And The Ugly Of COVID-19 Vaccine Manufacturing Technology Platforms
Not all technology platforms provide the expected benefit of filling in CMC review gaps and speeding coronavirus vaccine approvals.
Stability Genius: How CMC Section Of COVID-19 Vaccine Guidance Speeds EUAs Safely
By focusing on short-term stability, US FDA paves way for quicker emergency use authorization without compromising on quality.
Why Generic Drug Manufacturing Is Faltering And Ways To Bolster It
Academic expert provides insight into the economic and quality challenges behind generic drug shortages, and what to do about it.